To receive our website updates, please enter your email address below.

Mitsubishi Chemical Holdings Corporation 2008 CSR Report and 2009 Web Pages

For More Information
To learn more about how we score, what topics are considered in the evaluation, and what score we assigned in each topic, click here: View the completed PSI scoring sheet

Analyst Comments
Mitsubishi Chemical Holdings Corporation’s (MCHC) efforts toward corporate social responsibility are discussed in its 2008 Corporate Social Responsibility Report. MCHC has made environmental progress by appointing leaders, creating management structures, and implementing programs with the purpose of sustainability. In 2008, it hired a Chief Sustainability Officer, and it is currently working to develop an internal environmental management system. MCHC clearly explains its dedication and desire to become as responsible a company as possible. MCHC is a holding company for Mitsubishi Chemical, Mitsubishi Pharma and Mitsubishi Plastics. As such, MCHC puts heavy emphasis on using its resources to develop what it calls “good chemistry”; chemistry that is less wasteful, non-toxic, and bio-derived for more efficient and safe processes and products. One weakness of the report is the lack of disclosure of environmental or social data to give stakeholders a true sense of the company’s current performance. While this may be due to the separation of its subsidiaries, compiling and publishing these performance data in one report would be beneficial for overall transparency. Analyzed by Brittany Nunnink, and posted to the web on 2/3/2009.

Company Description
Mitsubishi Chemical Holdings was created in 2005 as a holding company for Mitsubishi Chemical and Mitsubishi Tanabe Pharma. As the largest chemical company in Japan, Mitsubishi Chemical (MCC) produces a wide variety of petrochemicals, specialty chemicals, and the like. Other products include plastics and films, data storage devices such as CDs and DVDs, as well as chemicals for semiconductor manufacturing. Mitsubishi Tanabe Pharma makes pharmaceutical products for central nervous system, cardiovascular, and gastrointestinal disorders, in addition to OTC and anti-inflammatory drugs. The company owns 56% of the pharmaceutical unit after the former Mitsubishi Pharma merged with the former Tanabe Seiyaku. Source: http://premium.hoovers.com/subscribe/co/factsheet.xhtml?ID=rcfxjfkrrtyrkhx

Overall Scores

The letter grades reported below are based on all reports irrespective of year of the same sector in the database and may be slightly different from the grades in the individual sector reports, which are based on scores of companies in just that report.

Search the REC website using:
Search WWW Search REC